Biotech PYC seeks $653m cash via new equity raising
SYDNEY: PYC Therapeutics, a developer of RNA therapies for genetic diseases and capitalised at $933
SYDNEY: PYC Therapeutics, a developer of RNA therapies for genetic diseases and capitalised at $933
FEATURED
Best retirement housing design for Global Awards shortlisted
Investor in 28 per cent jump on seniors housing demand
‘All in’ housing hub for disabled adults and seniors being developed
Buyers still frustrated by a year of delays at boomer development
City set to oppose 87-apartment boomer development
Scheme allows care providers to make ‘virtual visits’ to innovation hubs
INNOVATION
